[ET Net News Agency, 19 August 2021] Guangzhou Baiyunshan Pharmaceutical Holdings
Company Limited (00874) said its net profit attributable to the shareholders of the
company was RMB2.5 billion for the six months ended 30 June 2021, a year-on-year increase
of 41.84%. No dividend will be distributed.
Income from operations was RMB36.13 billion, a year-on-year increase of 18.57%. (RC)